Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection - A randomized trial

  • Fred Poordad
  • , Eric Lawitz
  • , K. Rajender Reddy
  • , Nezam H. Afdhal
  • , Christophe Hézode
  • , Stefan Zeuzem
  • , Samuel S. Lee
  • , Jose Luis Calleja
  • , Robert S. Brown
  • , Antonio Craxi
  • , Heiner Wedemeyer
  • , Lisa Nyberg
  • , David R. Nelson
  • , Lorenzo Rossaro
  • , Luis Balart
  • , Timothy R. Morgan
  • , Bruce R. Bacon
  • , Steven L. Flamm
  • , Kris V. Kowdley
  • , Weiping Deng
    • Kenneth J. Koury, Lisa D. Pedicone, Frank J. Dutko, Margaret H. Burroughs, Katia Alves, Janice Wahl, Clifford A. Brass, Janice K. Albrecht, Mark S. Sulkowski

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection - A randomized trial'. Together they form a unique fingerprint.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science